BDBM50303055 1-(6-(2-aminopyrazolo[1,5-a]pyrimidin-3-yl)pyrimidin-4-yl)-N,N-dipropylpiperidine-3-carboxamide::CHEMBL569091

SMILES: CCCN(CCC)C(=O)C1CCCN(C1)c1cc(ncn1)-c1c(N)nn2cccnc12

InChI Key: InChIKey=HVXCOLYHVNHNKP-UHFFFAOYSA-N

Data: 3 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 50303055   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Tyrosine-protein kinase JAK2 (Homo sapiens (Human))	BDBM50303055 (1-(6-(2-aminopyrazolo[1,5-a]pyrimidin-3-yl)pyrimid...) Show SMILES CCCN(CCC)C(=O)C1CCCN(C1)c1cc(ncn1)-c1c(N)nn2cccnc12 Show InChI InChI=1S/C22H30N8O/c1-3-9-28(10-4-2)22(31)16-7-5-11-29(14-16)18-13-17(25-15-26-18)19-20(23)27-30-12-6-8-24-21(19)30/h6,8,12-13,15-16H,3-5,7,9-11,14H2,1-2H3,(H2,23,27)	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	4.70	n/a	n/a	n/a	n/a	n/a	n/a
Vertex Pharmaceuticals Inc Curated by ChEMBL					Assay Description Inhibition of JAK2 by radiometric assay				Bioorg Med Chem Lett 19: 6529-33 (2009) Article DOI: 10.1016/j.bmcl.2009.10.053 BindingDB Entry DOI: 10.7270/Q2SJ1MKQ
					More data for this Ligand-Target Pair
Tyrosine-protein kinase JAK2 (Homo sapiens (Human))	BDBM50303055 (1-(6-(2-aminopyrazolo[1,5-a]pyrimidin-3-yl)pyrimid...) Show SMILES CCCN(CCC)C(=O)C1CCCN(C1)c1cc(ncn1)-c1c(N)nn2cccnc12 Show InChI InChI=1S/C22H30N8O/c1-3-9-28(10-4-2)22(31)16-7-5-11-29(14-16)18-13-17(25-15-26-18)19-20(23)27-30-12-6-8-24-21(19)30/h6,8,12-13,15-16H,3-5,7,9-11,14H2,1-2H3,(H2,23,27)	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	1.90E+3	n/a	n/a	n/a	n/a	n/a	n/a
Vertex Pharmaceuticals Inc Curated by ChEMBL					Assay Description Inhibition of JAK2-mediated STAT5 phosphorylation in GMCSF-stimulated human TF1 cells				Bioorg Med Chem Lett 19: 6529-33 (2009) Article DOI: 10.1016/j.bmcl.2009.10.053 BindingDB Entry DOI: 10.7270/Q2SJ1MKQ
					More data for this Ligand-Target Pair
Tyrosine-protein kinase JAK3 (Homo sapiens (Human))	BDBM50303055 (1-(6-(2-aminopyrazolo[1,5-a]pyrimidin-3-yl)pyrimid...) Show SMILES CCCN(CCC)C(=O)C1CCCN(C1)c1cc(ncn1)-c1c(N)nn2cccnc12 Show InChI InChI=1S/C22H30N8O/c1-3-9-28(10-4-2)22(31)16-7-5-11-29(14-16)18-13-17(25-15-26-18)19-20(23)27-30-12-6-8-24-21(19)30/h6,8,12-13,15-16H,3-5,7,9-11,14H2,1-2H3,(H2,23,27)	PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	220	n/a	n/a	n/a	n/a	n/a	n/a
Vertex Pharmaceuticals Inc Curated by ChEMBL					Assay Description Inhibition of JAK3 by radiometric assay				Bioorg Med Chem Lett 19: 6529-33 (2009) Article DOI: 10.1016/j.bmcl.2009.10.053 BindingDB Entry DOI: 10.7270/Q2SJ1MKQ
					More data for this Ligand-Target Pair